|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
52761 |
| 003 |
KOHA_MIRAKIL |
| 008 |
100526s2009 usaf 00010 eng |
| 020 |
|
|
|a 9789264076792
|
| 040 |
|
|
|a TR-AnSBB
|b tur
|c TR-AnSBB
|
| 082 |
|
|
|a 615.7/PHA
|
| 245 |
|
|
|a Pharmacogenetics: opportunities and challenges for health innovation.
|
| 260 |
|
|
|a Paris:
|b OECD,
|c 2009.
|
| 300 |
|
|
|a 131 p. :
|b ill.
|
| 440 |
|
|
|a OECD innovation strategy
|
| 500 |
|
|
|a "This work is published on the responsibility of the Secretary-General of the OECD"--T.p. verso.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
|
|a Pharmacogenetics
|
| 650 |
|
|
|a Farmakogenetik
|
| 650 |
|
|
|a Pharmaceutical industry
|b Technological innovations
|
| 650 |
|
|
|a Farmakoloji endüstrisi
|x Teknolojik yenilikler
|
| 710 |
|
|
|a Organisation for Economic Co-operation and Development. Secretary-General (OECD)
|
| 740 |
|
|
|a Opportunities and challenges for health innovation
|
| 856 |
|
|
|3 E-ERİŞİM
|u http://www.sourceoecd.org/9789264076792
|
| 942 |
|
|
|2 ddc
|c BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_PHA_K
|7 0
|9 84941
|a SBB
|b SBB
|c Kütüphane
|d 2010-05-26
|e BAGIS
|o 615.7 PHA K
|p 0029865
|r 2010-05-26 00:00:00
|w 2010-05-26
|y BK
|
| 999 |
|
|
|c 52761
|d 52761
|
